What is the workup for cholestasis of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Cholestasis of Pregnancy

Measure serum bile acids and liver transaminases (ALT/AST) in any pregnant woman with pruritus, particularly if it occurs in the second or third trimester without a rash. 1

Initial Laboratory Testing

The diagnostic workup centers on two key tests:

  • Serum total bile acids: The most sensitive and specific marker for intrahepatic cholestasis of pregnancy (ICP), with levels >10 μmol/L considered diagnostic (though some labs use >11 μmol/L as the threshold) 1
  • Liver transaminases (ALT and AST): Elevated in most cases, though not required for diagnosis; typically <500 U/L in ICP 1, 2

Use enzymatic bile acid assays when rapid results are needed (4 hours to 4 days turnaround), rather than mass spectrometry methods that take 4-14 days. 1 Random (non-fasting) bile acid levels are acceptable and more convenient than fasting samples, as the difference between fasting and postprandial values is clinically insignificant. 1

Differential Diagnosis Testing

Before confirming ICP, exclude life-threatening conditions that can mimic it:

High-Priority Exclusions

  • Pre-eclampsia/HELLP syndrome: Check complete blood count (platelets), LDH, blood pressure, and proteinuria 2
  • Acute fatty liver of pregnancy (AFLP): Assess coagulation studies (PT/INR), glucose, and bilirubin 2
  • Viral hepatitis: Consider hepatitis panel, particularly hepatitis C (which increases ICP risk 3.5-fold) 1, 2

Additional Workup for Atypical Presentations

  • Hepatobiliary ultrasound: To exclude gallstones and biliary obstruction 2
  • Thyroid function tests: If symptoms suggest thyroid disorder 2
  • Renal function tests: To exclude renal causes of pruritus 2
  • Gamma-GT: If elevated, consider ABCB4 deficiency or primary biliary/sclerosing cholangitis 2

Clinical Assessment Details

History Elements to Document

  • Timing of pruritus onset: ICP typically begins in late second or third trimester 1
  • Location and pattern: Pruritus often affects palms and soles, worsens at night 1
  • Prior pregnancy history: Up to 90% recurrence risk in subsequent pregnancies 1
  • Family history: Familial clustering suggests genetic susceptibility 1
  • Pre-existing liver disease: Hepatitis C, cirrhosis, gallstones increase risk 1

Physical Examination Findings

  • Absence of primary rash: Only excoriations from scratching should be present; any primary dermatologic lesions suggest alternative diagnoses (atopic eruption of pregnancy, polymorphic eruption of pregnancy, pemphigoid gestationis) 1, 2
  • Jaundice: Uncommon in ICP (only 10-15% of cases); if present with bilirubin >5 mg/dL, consider alternative diagnoses 2
  • Dark urine: Not typical of ICP; suggests other hepatic pathology 1

Critical Pitfalls to Avoid

Never deliver before 37 weeks based on clinical suspicion alone without laboratory confirmation of elevated bile acids. 1 The pruritus can precede bile acid elevation by several weeks, so if initial testing is normal but symptoms persist, repeat bile acids and transaminases. 1

Do not assume ICP without excluding HELLP syndrome and AFLP, as these conditions carry significant maternal mortality risk and require immediate delivery regardless of gestational age. 2 The combination of elevated LDH, low platelets, and hemolysis points to HELLP rather than ICP. 2

Follow-Up Testing

  • Repeat bile acids if symptoms persist with initially normal results: Bile acid levels can increase rapidly, particularly near term 1
  • Serial weekly testing is not routinely recommended, but repeat testing at 4-6 weeks may guide delivery timing in severe cases 1
  • Postpartum follow-up: If symptoms or abnormal labs persist 4-6 weeks after delivery, refer to hepatology for evaluation of underlying hepatobiliary disease 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnosis of Intrahepatic Cholestasis of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.